{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:04:26Z","timestamp":1793642666668,"version":"4.5.1"},"reference-count":58,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T00:00:00Z","timestamp":1239753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2009,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> There has been no report on the response to proton pump inhibitor (PPI) therapy and on\u2010demand or the relapse rate of non\u2010erosive reflux disease (NERD) and erosive oesophagitis in Korea.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold> To compare the risk factors, clinical symptoms and PPI responses between patients with erosive oesophagitis and NERD patients.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> A survey was performed prospectively in the erosive oesophagitis (205 patients) and NERD group (200 patients). Clinical symptoms, risk factors and PPI responses were analysed. On\u2010demand therapy and the relapse rate of GERD symptoms were investigated during a one\u2010year follow\u2010up.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> BMI\u2003\u2265\u200325 (OR 3.0, 95% CI 1.1\u20138.3), alcohol use (OR 2.9, 95% CI 1.0\u20138.3), hiatal hernia (OR 5.0, 95% CI 1.2\u201320) and triglyceride \u2265150\u2003mg\/dL (OR 4.0, 95% CI 1.7\u201310) were more common in the erosive oesophagitis group than in the NERD group by multivariate analysis. The ratio of oesophageal to extra\u2010oesophageal symptoms was higher in the erosive oesophagitis group compared with the NERD group (<jats:italic>P\u2003<\/jats:italic>&lt;<jats:italic>\u2003<\/jats:italic>0.001). The PPI response rates at 8\u2003weeks were different (<jats:italic>P\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>0.02); refractory rates were higher in the NERD group (16.7%) compared with the erosive oesophagitis group (6.0%). However, there was no significant difference between the two groups in on\u2010demand therapy or the relapse rate.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> These results suggest that the underlying pathogenic mechanisms of erosive oesophagitis and NERD are distinct.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2009.04021.x","type":"journal-article","created":{"date-parts":[[2009,4,16]],"date-time":"2009-04-16T01:47:26Z","timestamp":1239846446000},"page":"154-164","source":"Crossref","is-referenced-by-count":53,"title":["Comparison of risk factors and clinical responses to proton pump inhibitors in patients with erosive oesophagitis and non\u2010erosive reflux disease"],"prefix":"10.1111","volume":"30","author":[{"given":"E. S.","family":"LEE","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"KIM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. H.","family":"LEE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. S.","family":"PARK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. W.","family":"KIM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. H.","family":"JEONG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. H.","family":"LEE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. C.","family":"JUNG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. S.","family":"SONG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,6,26]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00630.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)90287-F"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365520410003498"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1159\/000007521"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000225631.07039.6d"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.051821"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02798.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199802000-00004"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.08.014"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(04)00288-5"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03381.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68932-0"},{"key":"e_1_2_6_14_2","first-page":"CD003245","article-title":"Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease","author":"Donnellan C","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1159\/000101085"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01737.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02198.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01377.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v10.i11.1647"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2004.03521.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365520310004506"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.41245.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365520510015610"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2001.02464.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01373.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018835324210"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s005350050293"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2003.02932.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200405000-00010"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03561.x"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(05)00860-8"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00882.x"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07665.x"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)15268-3"},{"key":"e_1_2_6_35_2","first-page":"1053","article-title":"Gastroesophageal reflux disease in the elderly: more severe disease that requires aggressive therapy","volume":"90","author":"Collen MJ","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-143-3-200508020-00006"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.147090"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.057497"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1023\/B:DDAS.0000007857.15694.15"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.40966.x"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i20.3091"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2000.02148.x"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2004.03419.x"},{"key":"e_1_2_6_44_2","first-page":"1","article-title":"The clinical spectrum of gastroesophagel reflux disease in Korea","volume":"6","author":"Lee S","year":"2000","journal-title":"Korean J Neurogastroenterol and Motiity"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.45.2.172"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.12.1810"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.44186000.x"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529709011211"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.12.1803"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00185.x"},{"key":"e_1_2_6_51_2","first-page":"1749","article-title":"Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group","volume":"91","author":"Castell DO","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03600.x"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.03254.x"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00363.x"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00904.x"},{"key":"e_1_2_6_56_2","first-page":"37","article-title":"Natural course of gastroesophageal reflux disease: 17\u201322\u2003year follow\u2010up of 60 patients","volume":"92","author":"Isolauri J","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_57_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00564.x"},{"key":"e_1_2_6_58_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02553.x"},{"key":"e_1_2_6_59_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365520212499"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2009.04021.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2009.04021.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T20:09:19Z","timestamp":1697227759000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2009.04021.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,26]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["10.1111\/j.1365-2036.2009.04021.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2009.04021.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,26]]}}}